343 related articles for article (PubMed ID: 36975758)
1. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
Maurya S; Srivastava R; Arfin S; Hawthorne S; Jha NK; Agrawal K; Raj S; Rathi B; Kumar A; Raj R; Agrawal S; Paiva-Santos AC; Malik AA; Dua K; Rana R; Ojha S; Jha SK; Sharma A; Kumar D; El-Zahaby SA; Nagar A
Nanomedicine (Lond); 2022 Dec; 17(30):2245-2264. PubMed ID: 36975758
[TBL] [Abstract][Full Text] [Related]
2. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
3. Nano based drug delivery systems: recent developments and future prospects.
Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.
Lembo D; Donalisio M; Civra A; Argenziano M; Cavalli R
Expert Opin Drug Deliv; 2018 Jan; 15(1):93-114. PubMed ID: 28749739
[TBL] [Abstract][Full Text] [Related]
5. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
Hock SC; Ying YM; Wah CL
PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.
Kompella UB; Amrite AC; Pacha Ravi R; Durazo SA
Prog Retin Eye Res; 2013 Sep; 36():172-98. PubMed ID: 23603534
[TBL] [Abstract][Full Text] [Related]
7. Medical nanoparticles for next generation drug delivery to the lungs.
van Rijt SH; Bein T; Meiners S
Eur Respir J; 2014 Sep; 44(3):765-74. PubMed ID: 24791828
[TBL] [Abstract][Full Text] [Related]
8. An Overview of Green Synthesis and Potential Pharmaceutical Applications of Nanoparticles as Targeted Drug Delivery System in Biomedicines.
Mittal S; Chakole CM; Sharma A; Pandey J; Chauhan MK
Drug Res (Stuttg); 2022 Jun; 72(5):274-283. PubMed ID: 35562101
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
[TBL] [Abstract][Full Text] [Related]
11. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering.
Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P
Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218
[TBL] [Abstract][Full Text] [Related]
12. The new era of pancreatic cancer treatment: Application of nanotechnology breaking through bottlenecks.
Luo W; Zhang T
Cancer Lett; 2024 Jul; 594():216979. PubMed ID: 38795762
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology based therapeutics for lung disease.
Doroudian M; MacLoughlin R; Poynton F; Prina-Mello A; Donnelly SC
Thorax; 2019 Oct; 74(10):965-976. PubMed ID: 31285360
[TBL] [Abstract][Full Text] [Related]
14. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
Patel P; Shah J
Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
[TBL] [Abstract][Full Text] [Related]
15. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
Luo MX; Hua S; Shang QY
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine for Cystic Fibrosis.
Ong V; Mei V; Cao L; Lee K; Chung EJ
SLAS Technol; 2019 Apr; 24(2):169-180. PubMed ID: 30707858
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle Based Treatment for Cardiovascular Diseases.
Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology approaches for inhalation treatment of lung diseases.
Kuzmov A; Minko T
J Control Release; 2015 Dec; 219():500-518. PubMed ID: 26297206
[TBL] [Abstract][Full Text] [Related]
20. Recent Progress and Challenges in Clinical Translation of Nanomedicines in Diagnosis and Treatment of Lung Cancer.
Yadav B; Chauhan M; Singh RP; Sonali ; Shekhar S
Curr Drug Targets; 2024; 25(1):12-24. PubMed ID: 38058096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]